Shilpa Medicare’s equal joint venture with Zydus group - Oncosol - along with its partner company Shorla Oncology, has announced USFDA's approval for IMKELDI, the first oral liquid form of imatinib to ...

View all announcements for SHILPA MEDICARE LTD. Source: BSE India ...

Imkeldi is a new formulation of imatinib approved as a strawberry-flavored, shelf-stable liquid designed to be more appealing ...

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...

Tenax Therapeutics, Inc. (NASDAQ:TENX – Get Free Report) has been assigned an average rating of “Buy” from the five brokerages that are currently covering the firm, Marketbeat reports. Four equities ...

Tenax also is developing a unique oral formulation of imatinib. For more information, visit Tenax’s common stock is listed on The Nasdaq Stock Market LLC under the symbol “TENX”.

Detailed price information for Inhibikase Therapeutics Inc (IKT-Q) from The Globe and Mail including charting and trades.

News on Inhibikase's promising treatments for PAH and Parkinson's Disease, supported by FDA approval and substantial funding.

As consumers cope with lingering inflation, CBS News is tracking the change in prices of everyday household expenses — from food at the grocery store to utilities and even rent — across the ...

Figuring out the best time to buy something requires constant watch over ever-fluctuating online prices and some knowledge of how prices have changed in the past. As a shopping and deal writer ...

We believe IkT-001Pro, a prodrug of imatinib, has the potential to ameliorate the safety and tolerability profile that precluded approval of imatinib for the treatment of PAH more than 10 years ago.

Want to ensure you get the best price when you click 'Add to Cart' on Black Friday? Cut the guesswork and shop confidently with these money-saving apps. My title is Senior Features Writer ...